R.H. Investment Group’s Gossamer Bio GOSS Stock Holding History

R.H. Investment Group’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.33K	Hold	329	–	–	﹤0.01%	47
2026 Q1	$9.14K	Buy	+329	New	+$41.4K	0.01%	45

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

R.H. Investment Group's GOSS Position: Q2 2026 in Review

R.H. Investment Group held its Gossamer Bio (GOSS) position steady in Q2 2026 at 329 shares worth $4.33K. The position accounts for ﹤0.01% of the portfolio, ranked #47.

R.H. Investment Group first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.14K in Q1 2026. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

R.H. Investment Group held 329 shares of Gossamer Bio worth $4.33K as of Q2 2026.
R.H. Investment Group left its Gossamer Bio share count unchanged in Q2 2026.
Gossamer Bio made up ﹤0.01% of R.H. Investment Group's portfolio in Q2 2026, its #47 holding.
R.H. Investment Group first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
R.H. Investment Group's Gossamer Bio position peaked at $9.14K in Q1 2026.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on R.H. Investment Group's 13F filing for Q2 2026, filed 7 Aug 2026.